BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24844332)

  • 1. Effects of interleukin-10 on cutaneous wounds and scars in humans of African continental ancestral origin.
    Kieran I; Taylor C; Bush J; Rance M; So K; Boanas A; Metcalfe A; Hobson R; Goldspink N; Hutchison J; Ferguson M
    Wound Repair Regen; 2014; 22(3):326-33. PubMed ID: 24844332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-10 reduces scar formation in both animal and human cutaneous wounds: results of two preclinical and phase II randomized control studies.
    Kieran I; Knock A; Bush J; So K; Metcalfe A; Hobson R; Mason T; O'Kane S; Ferguson M
    Wound Repair Regen; 2013; 21(3):428-36. PubMed ID: 23627460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies.
    Ferguson MW; Duncan J; Bond J; Bush J; Durani P; So K; Taylor L; Chantrey J; Mason T; James G; Laverty H; Occleston NL; Sattar A; Ludlow A; O'Kane S
    Lancet; 2009 Apr; 373(9671):1264-74. PubMed ID: 19362676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scar redness in humans: how long does it persist after incisional and excisional wounding?
    Bond JS; Duncan JAL; Mason T; Sattar A; Boanas A; O'Kane S; Ferguson MWJ
    Plast Reconstr Surg; 2008 Feb; 121(2):487-496. PubMed ID: 18300967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scar-improving efficacy of avotermin administered into the wound margins of skin incisions as evaluated by a randomized, double-blind, placebo-controlled, phase II clinical trial.
    Bush J; Duncan JAL; Bond JS; Durani P; So K; Mason T; O'Kane S; Ferguson MWJ
    Plast Reconstr Surg; 2010 Nov; 126(5):1604-1615. PubMed ID: 21042116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiscarring pharmaceuticals: lost in translation?
    Agren MS; Danielsen PL
    Wound Repair Regen; 2014; 22(3):293-4. PubMed ID: 24844327
    [No Abstract]   [Full Text] [Related]  

  • 7. Avotermin for scar improvement following scar revision surgery: a randomized, double-blind, within-patient, placebo-controlled, phase II clinical trial.
    So K; McGrouther DA; Bush JA; Durani P; Taylor L; Skotny G; Mason T; Metcalfe A; O'Kane S; Ferguson MWJ
    Plast Reconstr Surg; 2011 Jul; 128(1):163-172. PubMed ID: 21701333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Orf virus IL-10 accelerates wound healing while limiting inflammation and scarring.
    Wise LM; Stuart GS; Real NC; Fleming SB; Mercer AA
    Wound Repair Regen; 2014; 22(3):356-67. PubMed ID: 24844335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of scar spread on trunk excisions: a rater-blinded randomized controlled trial.
    Kia KF; Burns MV; Vandergriff T; Weitzul S
    JAMA Dermatol; 2013 Jun; 149(6):687-91. PubMed ID: 23752288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scar-free healing: from embryonic mechanisms to adult therapeutic intervention.
    Ferguson MW; O'Kane S
    Philos Trans R Soc Lond B Biol Sci; 2004 May; 359(1445):839-50. PubMed ID: 15293811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Topical Losartan in Management of Mammoplasty and Abdominoplasty Scars: A Randomized, Double-Blind Clinical Trial.
    Khodaei B; Nasimi M; Nassireslami E; Seyedpour S; Rahmati J; Haddady Abianeh S; Motavalli Khiavi F
    Aesthetic Plast Surg; 2022 Oct; 46(5):2580-2587. PubMed ID: 35614156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early intervention with non-ablative fractional laser to improve cutaneous scarring-A randomized controlled trial on the impact of intervention time and fluence levels.
    Karmisholt KE; Wenande E; Thaysen-Petersen D; Philipsen PA; Paasch U; Haedersdal M
    Lasers Surg Med; 2018 Jan; 50(1):28-36. PubMed ID: 28815643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of brain natriuretic peptide on scar formation in incisional rat wounds.
    Taira BR; Singer AJ; McClain SA; Zimmerman T
    Acad Emerg Med; 2008 Oct; 15(10):945-8. PubMed ID: 18795903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of the inflammatory response by increasing fetal wound size or interleukin-10 overexpression determines wound phenotype and scar formation.
    Morris MW; Allukian M; Herdrich BJ; Caskey RC; Zgheib C; Xu J; Dorsett-Martin W; Mitchell ME; Liechty KW
    Wound Repair Regen; 2014; 22(3):406-14. PubMed ID: 24844340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Randomized, Placebo-Controlled, Double-Blind, Prospective Clinical Trial of Botulinum Toxin Type A in Prevention of Hypertrophic Scar Development in Median Sternotomy Wound.
    Li YH; Yang J; Liu JQ; Xie ST; Zhang YJ; Zhang W; Zhang JL; Zheng Z; Hu DH
    Aesthetic Plast Surg; 2018 Oct; 42(5):1364-1369. PubMed ID: 30019241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-Dose Insulin as an Antiscarring Therapy in Breast Surgery: A Randomized Controlled Trial.
    Hallam MJ; Pitt E; Thomas A; Nduka C
    Plast Reconstr Surg; 2018 Apr; 141(4):476e-485e. PubMed ID: 29240641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The reinnervation and revascularization of wounds is temporarily altered after treatment with interleukin 10.
    Henderson J; Ferguson MW; Terenghi G
    Wound Repair Regen; 2011; 19(2):268-73. PubMed ID: 21362095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Double-Blind, Randomized Trial Shows the Role of Zonal Priming and Direct Topical Application of Epigallocatechin-3-Gallate in the Modulation of Cutaneous Scarring in Human Skin.
    Ud-Din S; Foden P; Mazhari M; Al-Habba S; Baguneid M; Bulfone-Paus S; McGeorge D; Bayat A
    J Invest Dermatol; 2019 Aug; 139(8):1680-1690.e16. PubMed ID: 30822414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of the embrace advanced scar therapy device to reduce incisional scar formation.
    Longaker MT; Rohrich RJ; Greenberg L; Furnas H; Wald R; Bansal V; Seify H; Tran A; Weston J; Korman JM; Chan R; Kaufman D; Dev VR; Mele JA; Januszyk M; Cowley C; McLaughlin P; Beasley B; Gurtner GC
    Plast Reconstr Surg; 2014 Sep; 134(3):536-546. PubMed ID: 24804638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Dermal Thickness on Scars in Women with Type III-IV Fitzpatrick Skin.
    Ince B; Dadaci M; Oltulu P; Altuntas Z; Bilgen F
    Aesthetic Plast Surg; 2015 Jun; 39(3):318-24. PubMed ID: 25787787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.